null

SMILES: CC(=O)c1cccc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(cc4CC3)C#N)CC2)c1

InChI Key: InChIKey=PIXRONAZKMZTPE-REAKQFRHSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50218412   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50218412 (CHEMBL419487) Show SMILES CC(=O)c1cccc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(cc4CC3)C#N)CC2)c1 |wU:13.12,wD:16.16,(30.39,-20.53,;28.85,-20.54,;28.08,-21.89,;28.05,-19.19,;28.82,-17.86,;28.05,-16.53,;26.51,-16.53,;25.74,-17.86,;24.2,-17.86,;23.43,-16.53,;21.89,-16.52,;21.1,-17.85,;21.12,-15.17,;19.58,-15.17,;18.81,-16.5,;17.27,-16.5,;16.5,-15.17,;14.96,-15.15,;14.19,-13.82,;12.65,-13.8,;11.98,-12.41,;10.48,-12.07,;9.29,-13.03,;7.96,-12.26,;6.63,-13.03,;6.63,-14.57,;7.96,-15.34,;9.29,-14.57,;10.48,-15.52,;11.98,-15.17,;5.28,-15.34,;3.93,-16.11,;17.27,-13.82,;18.81,-13.82,;26.51,-19.19,)| Show InChI InChI=1S/C30H35N3O2/c1-22(34)27-4-2-3-24(19-27)8-12-30(35)32-29-10-6-23(7-11-29)13-16-33-17-14-26-9-5-25(21-31)20-28(26)15-18-33/h2-5,8-9,12,19-20,23,29H,6-7,10-11,13-18H2,1H3,(H,32,35)/b12-8+/t23-,29-	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
SmithKline Beecham Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity towards human Dopamine receptor D3 by displacement of [125I]iodosulpiride expressed in CHO cells				Bioorg Med Chem Lett 10: 2553-5 (2000) BindingDB Entry DOI: 10.7270/Q24Q7X55
					More data for this Ligand-Target Pair
D(2) dopamine receptor (Homo sapiens (Human))	BDBM50218412 (CHEMBL419487) Show SMILES CC(=O)c1cccc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(cc4CC3)C#N)CC2)c1 |wU:13.12,wD:16.16,(30.39,-20.53,;28.85,-20.54,;28.08,-21.89,;28.05,-19.19,;28.82,-17.86,;28.05,-16.53,;26.51,-16.53,;25.74,-17.86,;24.2,-17.86,;23.43,-16.53,;21.89,-16.52,;21.1,-17.85,;21.12,-15.17,;19.58,-15.17,;18.81,-16.5,;17.27,-16.5,;16.5,-15.17,;14.96,-15.15,;14.19,-13.82,;12.65,-13.8,;11.98,-12.41,;10.48,-12.07,;9.29,-13.03,;7.96,-12.26,;6.63,-13.03,;6.63,-14.57,;7.96,-15.34,;9.29,-14.57,;10.48,-15.52,;11.98,-15.17,;5.28,-15.34,;3.93,-16.11,;17.27,-13.82,;18.81,-13.82,;26.51,-19.19,)| Show InChI InChI=1S/C30H35N3O2/c1-22(34)27-4-2-3-24(19-27)8-12-30(35)32-29-10-6-23(7-11-29)13-16-33-17-14-26-9-5-25(21-31)20-28(26)15-18-33/h2-5,8-9,12,19-20,23,29H,6-7,10-11,13-18H2,1H3,(H,32,35)/b12-8+/t23-,29-	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	200	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
SmithKline Beecham Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells				Bioorg Med Chem Lett 10: 2553-5 (2000) BindingDB Entry DOI: 10.7270/Q24Q7X55
					More data for this Ligand-Target Pair